Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Methods in Molecular Medicine|December 9, 2004
Generation of clinical-grade monocyte-derived dendritic cells using the CliniMACS systemThomas Putz, Hubert Gander, Reinhold Ramoner, et al.
The Prostate|March 9, 2005
Small G-protein RhoE is underexpressed in prostate cancer and induces cell cycle arrest and apoptosisJasmin Bektic, Karina Pfeil, Andreas Paul Berger, et al.
Cancer Immunology, Immunotherapy : CII|May 27, 2005
Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamideLorenz Höltl, Reinhold Ramoner, Claudia Zelle-Rieser, et al.
Clinical Prostate Cancer|January 8, 2005
Measurement of intracellular versus extracellular prostate-specific antigen levels in peripheral macrophages: a new approach to noninvasive diagnosis of prostate cancerRalf Herwig, Alexandre Pelzer, Wolfgang Horninger, et al.
The Prostate|September 25, 2004
Ability of PSA-positive circulating macrophages to detect prostate cancerRalf Herwig, Wolfgang Horninger, Peter Rehder, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 27, 2013
Attenuation of nucleoside and anti-cancer nucleoside analog drug uptake in prostate cancer cells by Cimicifuga racemosa extract BNO-1055Andrea Dueregger, Fabian Guggenberger, Jan Barthelmes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinomaKarin Jöhrer, Claudia Zelle-Rieser, Alexander Perathoner, et al.
Plos One|August 19, 2015
Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the ProstateAndrea Dueregger, Bernd Schöpf, Theresa Eder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cellsLorenz Höltl, Claudia Zelle-Rieser, Hubert Gander, et al.
BJU International|February 12, 2008
Pathological features of Gleason score 6 prostate cancers in the low and intermediate range of prostate-specific antigen level: is there a difference?Alexandre E Pelzer, Daniela Colleselli, Jasmin Bektic, et al.
Pageof 3